Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MELANIE WAHL

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1609072933
CMS profile
163121
Location
LAKEWOOD RANCH, FL

General Payments · PY2018–2024

$1,425.62

  • Reported across 87 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$538.30

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $470.50 32
Education $67.80 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $195.45 17
NOVARTIS PHARMACEUTICALS CORPORATION $86.10 5
E.R. Squibb & Sons, L.L.C. $67.80 4
Amgen Inc. $65.89 4
Acerta Pharma LLC $46.34 2
UCB, Inc. $38.28 2
PFIZER INC. $19.23 1
ANI Pharmaceuticals, Inc. $19.21 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $118.06 2
PY2019 $62.50 1
PY2020 $74.14 5
PY2021 $39.67 3
PY2022 $198.20 18
PY2023 $394.75 22
PY2024 $538.30 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1.95 01/24/2024 Food and Beverage Undisputed 01/23/2026 1106296537 CMS
ABBVIE INC. $4.30 03/06/2024 Food and Beverage Undisputed 01/23/2026 1106296539 CMS
ABBVIE INC. $26.31 04/15/2024 Food and Beverage Undisputed 01/23/2026 1106296541 CMS
ABBVIE INC. $1.84 04/17/2024 Food and Beverage Undisputed 01/23/2026 1106296543 CMS
ABBVIE INC. $3.71 04/24/2024 Food and Beverage Undisputed 01/23/2026 1106296545 CMS
ABBVIE INC. $2.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1106296547 CMS
ABBVIE INC. $27.92 07/22/2024 Food and Beverage Undisputed 01/23/2026 1106296549 CMS
ABBVIE INC. $1.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1106296551 CMS
ABBVIE INC. $23.78 09/16/2024 Food and Beverage Undisputed 01/23/2026 1106296553 CMS
ABBVIE INC. $1.96 10/02/2024 Food and Beverage Undisputed 01/23/2026 1106296555 CMS
ABBVIE INC. $15.47 10/04/2024 Food and Beverage Undisputed 01/23/2026 1106296557 CMS
ABBVIE INC. $33.37 10/07/2024 Food and Beverage Undisputed 01/23/2026 1106296559 CMS
ABBVIE INC. $1.75 11/12/2024 Food and Beverage Undisputed 01/23/2026 1106296561 CMS
ABBVIE INC. $16.54 12/02/2024 Food and Beverage Undisputed 01/23/2026 1106296563 CMS
ABBVIE INC. $5.81 12/06/2024 Food and Beverage Undisputed 01/23/2026 1106296565 CMS
ABBVIE INC. $20.22 12/06/2024 Food and Beverage Undisputed 01/23/2026 1106296567 CMS
ABBVIE INC. $6.37 12/12/2024 Food and Beverage Undisputed 01/23/2026 1106296569 CMS
Amgen Inc. $14.58 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116198247 CMS
Amgen Inc. $14.41 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116198255 CMS
Amgen Inc. $22.08 07/24/2024 Food and Beverage Undisputed 01/23/2026 1116198251 CMS
Amgen Inc. $14.82 12/03/2024 Food and Beverage Undisputed 01/23/2026 1117408953 CMS
ANI Pharmaceuticals, Inc. $19.21 05/03/2024 Food and Beverage Undisputed 01/23/2026 1091139198 CMS
AstraZeneca Pharmaceuticals LP $16.60 02/12/2024 Food and Beverage Undisputed 01/23/2026 1104508052 CMS
AstraZeneca Pharmaceuticals LP $29.74 11/11/2024 Food and Beverage Undisputed 01/23/2026 1105678061 CMS
E.R. Squibb & Sons, L.L.C. $14.80 01/25/2024 Education Undisputed 01/23/2026 1101434853 CMS
E.R. Squibb & Sons, L.L.C. $14.80 02/26/2024 Education Undisputed 01/23/2026 1101434857 CMS
E.R. Squibb & Sons, L.L.C. $19.10 02/26/2024 Education Undisputed 01/23/2026 1101434859 CMS
E.R. Squibb & Sons, L.L.C. $19.10 02/26/2024 Education Undisputed 01/23/2026 1101434861 CMS
Novartis Pharmaceuticals Corporation $17.93 02/02/2024 Food and Beverage Undisputed 01/23/2026 1087411722 CMS
Novartis Pharmaceuticals Corporation $16.40 03/04/2024 Food and Beverage Undisputed 01/23/2026 1087411724 CMS
Novartis Pharmaceuticals Corporation $22.44 06/17/2024 Food and Beverage Undisputed 01/23/2026 1087411726 CMS
Novartis Pharmaceuticals Corporation $15.35 09/06/2024 Food and Beverage Undisputed 01/23/2026 1087411728 CMS
Novartis Pharmaceuticals Corporation $13.98 11/01/2024 Food and Beverage Undisputed 01/23/2026 1087411730 CMS
PFIZER INC. $19.23 05/07/2024 Food and Beverage Undisputed 01/23/2026 1131689407 CMS
UCB, Inc. $15.60 09/09/2024 Food and Beverage Undisputed 01/23/2026 1143108880 CMS
UCB, Inc. $22.68 12/16/2024 Food and Beverage Undisputed 01/23/2026 1143108882 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.